Lecturer: Dr. Ana Đorđević, Department of Biochemistry, Institute for Biological Research "Siniša Stanković" - National Institute of the Republic of Serbia, University of Belgrade
Time: Wednesday, 29th April 2026, 13.00
Venue: IBISS Library
The seminar will present the latest research results from the Department of Biochemistry, whose main goal was to examine the potential of intestinal microbiota as a therapeutic target for metabolic diseases such as obesity and fatty liver. Special attention will be given to the recently completed clinical study that examined the effectiveness of LiverDophilus probiotic, developed at IBISS in cooperation with colleagues from IMGGI and the pharmaceutical company Phytonet. The seminar will also discuss how studies on mice enabled the development of this probiotic and its path from the laboratory to the pharmacy.
IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.